VAKCINA

Od sutra bez zakazivanja i "Sinofarm" vakcina

Direktor Kancelarije za e-Upravu Mihailo Jovanović kaže za RTS da će od sutra na svim vakcinalnim punktovima širom Srbije biti omogućeno vakcinisanje bez zakazivanja sa tri vakcine – "Fajzer", "sputnjik V" i "Sinofarm" vakcinom.

Mihailo Jovanović je, gostujući u Jutarnjem dnevniku RTS-a, naveo da je prošle nedelje počela vakcinacija bez zakazivanja "Fajzerovom" i "sputnjik V" vakcinom, a da se danas ta akcija nastavlja.

Ukazao je da je više desetina hiljada građana iskoristilo tu šansu i još jedan pozvao građane da odu u najbliži dom zdravlja i masovni punkt, jer je na svim punktovima u Srbiji omogućena vakcinacija bez zakazivanja.

Naveo je da je dobra vest da će od sutra biti omogućema vakcinacija bez zakazivanja i "Sinofarm" vakcinom.

"U toku dana stiže 500.000 doza 'Sinofarmovih' vakcina, tako da ćemo sutra odmah pozvati one građane koji su zakazali preko portala e-Uprave, ali ćemo sutra slobodno pustiti vakcinaciju i 'Sinofarm' vakcinom, dakle bez zakazivanja", rekao je Jovanović.

Poručio je da je počev od sutra za tri vakcine slobodno vakcinisanje bez zakazivanja na svim punktovima u Srbiji.

Govoreći o tome kakvi su dosadašnji podaci o vakcinaciji, Jovanović je rekao da podaci od jutros pokazuju da je do sada u Srbiji dato 3.255.000 vakcina, od toga je prva doza 1.945.000, a druga doza negde oko 1.310.000 vakcina.

"Broj građana koji su imunizovani je negde oko 1.200.000. To su oni građani gde je prošlo tri nedelje od druge doze, odnosno pet nedelja od prve doze kada je u pitanju 'Astra-Zeneka'", istakao je Jovanović.

Gde je najviše, a gde najmanje vakcinisanih

Jovanović je naveo da očekuje da do kraja dana bude data milionita doza vakcine u Beogradu.

"To je veoma značajno za glavni grad koji je motor i privrednog i trgovinskog razvoja i turizma i jednostavno zavisi od lokalne samouprave do lokalne samouprave kakav je odziv na vakcinaciju. Sigurno je Beograd jedan od najboljih", dodao je Jovanović.

Istakao je da pored beogradskih opština, koje su na vrhu tabele po broju vakcinisanih, više od 35 odsto punoletnih građana je vakcinisano u Nišu, Užicu, Sremskoj Mitrovici, Priboju, Novom Sadu, Kladovu, Kikindi, Malom Zvorniku, Sremskim Karlovcima, Kragujevcu, Požarevcu i Knjaževcu.

Najmanje vakcinisanih, ispod 20 odsto, imaju Tutin, Novi Pazar, Lajkovac, Mionica, Žagubica, Rača, Bujanovac, Ljig, Žitorađa, Boljevac, Vladimirci, Ražanj, Doljevac, Varvarin, Merošina, Krupanj, Sjenica i Osečina.

"Ovo je sada poziv gradonačelnicima i predsednicima opština, lokalnim samoupravama – sada je na njima, oni moraju organizovati svoje sugrađane, otići u svako selo i svako naselje, organizovati i nastaviti sa masovnom imunizacijom", rekao je Jovanović.

Među imunizovanima je, kaže Jovanović, 52 odsto žena, a najviše građana je primilo "Sinofarm" vakcinu.

Na pitanje koliko je do sada vakcinisano stranaca u našoj zemlji, Jovanović kaže da je do sada negde oko 39.000 stranaca primilo vakcinu u našoj zemlji.

"Oni mogu da se prijave preko portala e-Uprave, čak iako nemaju prijavljeno boravište u Srbiji, ali definitivno prioritet u ovom trenutku su naši državljani, maskimalni fokus u vakcinaciji su naši građani. Kada budemo završili vakcinaciju naših građana, ako bude dovoljno vakcina, razmišljaćemo da pozovemo i strane državljane", zaključio je Jovanović.

Moderna CEO says world faces 2022 COVID vaccine production surplus

Manufacturers should focus on producing as many vaccines as possible this year, but the world faces a potential surplus next year in capacity, Moderna's (MRNA.O) CEO said on Friday.

Speaking at a virtual event on vaccine manufacturing, Stephane Bancel said that additional technology transfers might dent their ability to meet production targets. Moderna is on track to make up to 1 billion doses this year and 1.4 billion next year, he said.

"Next year there is going to be way too many vaccines for people on the planet," he said.

He added that Moderna was working hard to have a booster vaccine against COVID-19 variants approved by the northern hemisphere late summer or early autumn.

Bancel, asked about shortages of workers at the Lonza (LONN.S)factory at Visp in the Swiss canton of Valais, which has a licence to make ingredients for its COVID-19 vaccine, but was confident that Lonza would close the gap there soon.

He also said that Moderna was in talks with the COVAX vaccine-sharing facility which is providing doses to lower income countries, adding: "I hope we are in the final stretch to get an agreement with COVAX."

The CDC is reporting troubling statistics when it comes to second doses of the Pfizer and Moderna COVID vaccine.

They believe 8 percent of Americans who got their first dose have not or will not get their second shot. While no one may want to go through the hassle of making two appointments, it is still necessary, and every expert agrees that you must follow the pharmaceutical's instructions. Except, more than five million Americans have not.

"We're out there trying to combat the degree of vaccine hesitancy that still is out there. And one of the real reasons why people have hesitancy is concern about the safety of the vaccine," said Dr. Anthony Fauci.

Some patients say a second dose of the same brand was not available when they came back for their second shot. Others say the hassles of booking appointments was not worth it, or that they had negative side effects the first time and didn't want to go through it again.

While there are lots of anecdotal reasons why people did not get a second dose, officials are encouraging Americans to follow the guidelines to get their second shot in the time frame that is recommended.

As industry lobbying has escalated in Washington, companies have warned in private meetings with US trade and White House officials that giving up the intellectual property rights could allow China and Russia to exploit platforms such as mRNA, which could be used for other vaccines or even therapeutics for conditions such as cancer and heart problems in the future.

BREAKING: A. Gintsburg, Gamaleya Inst. Director: It’s possible to increase the interval between 1st & 2nd Sputnik V vaccine shots from 21 days up to 3 months. Extending the interval won’t affect the immune response and may even enhance and prolong it.https://t.co/Yinpj1nygl

— Sputnik V (@sputnikvaccine) April 26, 2021

A Gintsburg: We believe that, given the exceptionally high demand for the vaccine, this decision would significantly expedite immunization. Each national regulator will decide whether to retain the 21-day interval between the shots or to extend it to up to 3 months.

— Sputnik V (@sputnikvaccine) April 26, 2021

The Brazilian health regulator Anvisa on Monday rejected importing the Russian-made Sputnik V COVID-19 vaccine requested by state governors battling a deadly second wave of the virus that is battering Latin America's largest nation.

Anvisa's five-strong board voted unanimously not to approve the Russian vaccine after technical staff had highlighted "inherent risks" and "serious" defects, citing a lack of information guaranteeing its safety, quality and effectiveness.

...Unanswered questions about the vaccine include basic biological data about its actions in the body, data on adverse events (including questions about thromboembolic events) ...2/n pic.twitter.com/sMuBquneLd

— Hilda Bastian, PhD (@hildabast) April 26, 2021

Spoiler:

Combatting malign influences in the Americas: OGA used diplomatic relations in the Americas region to mitigate efforts by states, including Cuba, Venezuela, and Russia, who are working to increase their influence in the region to the detriment of US safety and security. OGA coordinated with other U.S. government agencies to strengthen diplomatic ties and offer technical and humanitarian assistance to dissuade countries in the region from accepting aid from these illintentioned states. Examples include using OGA’s Health Attaché office to persuade Brazil to reject the Russian COVID-19 vaccine, and offering CDC technical assistance in lieu of Panama accepting an offer of Cuban doctors.

Batches of vaccine used in preclinical tests and clinical studies published in the Lancet [medical journal] do not have the same characteristics and properties as batches of vaccine imported to Slovakia,” the ŠÚKL wrote in its opinion

— Irene Tosetti (@itosettiMD_MBA) April 10, 2021

They said Russians failed to deliver 80% of the required documents and that the vaccine differed in its form (lyophilized vs. solution), doses per vial and storage requirements from the product described in the EMA documentation.

— Jiří Hudeček (@HuJirui) April 10, 2021

Građani koji žele da se vakcinišu protiv koronavirusa a nemaju zakazan termin mogu to danas da urade u hali 11 Beogradskog sajma, koja je je otvorena od 8.00 do 20.00 sati, izjavila je koordinatorka vakcinacije Dragana Milošević.

Milošević je za RTS izjavila da je u hali 11 u toku vakcinacija bez zakazivanja Fajzerovom vakcinom protiv koronavirusa.

Poziv za revakcinaciju, koja se odvija u hali 3, danas je dobilo 3.200 građana.

Milošević je navela da je prosečna starost onih koji su se bez zakazivanja vakcinisali tokom vikenda „oko 55 godina, što znači da je i mladja populacija dolazila“.

Prema njenim rečima, razmatra se plan kako će se raditi tokom praznika s obzirom na to da pojedine građane čeka druga doza vakcine. O tome će građani biti blagovremeno obavešteni.

Verovatno će se i narednih dana vršiti imunizacija bez zakazivanja - rekla je koordinatorka vakcinacije na Beogradskom sajmu dr Dragana Milošević

Preporuka Novosađanima da bez poziva eUprave danas ne dolaze na Novosadski sajam - očekuju se gužve
...
Glavni tehničar Doma zdravlja "Novi Sad", Nenad Vukas, kaže za 021.rs da od 8 do 14 časova dolazi 2.500 ljudi na drugu dozu vakcine, a od 14 do 20 časova 2.000 osoba sa pozivom eUprave na prvu dozu kineske Sinofarm vakcine.

Prema njegovim rečima, imaju dovoljne količine Fajzera, Sputnjika V, Astrazeneke i Sinofarm vakcine za svakoga ko želi, ali da građani, ukoliko im nije urgentno, sačekaju neki od narednih dana kako se ne bi pravile još veće gužve.